Alys Pharmaceuticals receives IND clearance for Phase 2a trial of first genetic medicine program in dermatology

Press/Media

Period	11 Feb 2025

Media coverage

Title	Alys Pharmaceuticals receives IND clearance for Phase 2a trial of first genetic medicine program in dermatology
Media name/outlet	Pharmaceutical Tech.com
Country/Territory	India
Date	11/02/25
URL	ct.moreover.com/?a=55997212488&p=1gw&v=1&x=vEIwCILynXuO-g_9jt_2cA
Persons	Brian Kim